- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03035123
Therapeutic Education Strategy for Patients With Acute Heart Failure (EduStra-HF)
Impact of an Intensive Therapeutic Education on Occurrence of Clinical Events in Patients With Acute Heart Failure: EduStra-HF Study
The EduStra-HF study will examine the impact of an intensive therapeutic education on patients discharged from hospital after an episode of acute heart failure (HF).
Patients will be randomized into two groups: one will receive "usual care" monitoring and one will receive a specific educational monitoring programme for 1 year.
All patients will meet with a specialized therapeutic education nurse before discharge.
The effect of the intensive education on HF rehospitalization and quality of life will be examined.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The prevalence of HF in France is increasing. According to a report from the Haute Autorité de Santé (HAS) - the French Health Authority - published in June 2015 concerning discharge of patients hospitalized for HF, 2.3% of the French adult population is affected. Despite improvements in treatment and HF-specific care, the rehospitalization rate for HF remains substantial, and HF management is a major public health issue.
Chronic HF leads to psychological and physiological issues in patients. Furthermore, this disease affects patient quality of life and activities of daily living.
The HAS also reported that even if iterative hospitalizations are the consequence of complicated and multifactorial situations, some could be prevented by improved patient care.
The aim of the EduStra-HF study is to examine the effect of an intensive therapeutic education on patients discharged from hospital after an episode of acute HF. It will study whether this intervention reduces the rate of rehospitalization and increases quality of life in this population.
To achieve this goal, a multicentre, randomized, two parallel arm study will be conducted. Patients will be included in several cardiology centres in Paris (Ile-de-France) over 2 years and 3 months.
Included patients, chosen from patients admitted for acute HF in the participating hospitals, will be randomized into two groups, which will determine the monitoring they receive after discharge. For each patient, monitoring will last for 1 year from the day they return home.
The first group of patients will be randomized to receive "usual care" monitoring and will not be given specific therapeutic education after discharge.
The second group (intervention arm) will receive a specific educational monitoring programme from nurses via telephone calls and home visits, for 1 year. Monitoring will began early after discharge. Annual medical monitoring and visits to the cardiologist will also be planned.
All patients, regardless of attribution arm, will meet a nurse trained in therapeutic education during their stay in hospital. Moreover, validated and HF-related self-assessed questionnaires will be analyzed to assess quality of life and impact of HF on patient activities of daily living.
In the interventional arm, patients will receive monitoring documents, such as a HF information booklet and a personal monitoring agenda.
The EduStra-HF study will provide a specific analysis of a multisupport therapeutic education (including medical monitoring). Data on all HF drug treatments, including the more recent ones (e.g. Entresto), blood tests results, and cardiologic data will be recorded.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Neuilly-sur-Seine, France, 92200
- Clinique Ambroise Pare
-
Paris, France, 75014
- Institut Mutualiste Montsouris
-
Paris, France, 75011
- Clinique du Mont Louis
-
Paris, France, 75012
- Hopital AP-HP Saint-Antoine
-
Saint Denis, France, 93200
- Centre Cardiologique du Nord
-
Versailles, France, 78000
- Centre Hospitalier André Mignot
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult patient with acute HF
- Affiliated to the French Social Security system
- Accepting the principle of telephone monitoring
- Accepting home visits from a study nurse
- Possession of a mobile phone
Exclusion Criteria:
Psychosocial:
- Refusal to accept the study design
- Patient under guardianship
- Monitoring obstacle: language, cognitive deficiency, itinerant lifestyle, regular travel, institutionalization
- Inability to sign the consent form or to complete questionnaires
Medical:
- Active cancer
- Severe psychiatric or neurological disorder
- Complicated acute myocardial infarction
- Significant valvular diseases requiring surgery
- Hypertrophic obstructive cardiomyopathy
- Planned heart transplant
- Cardiac surgery in the previous 3 months
- Enrollment in another clinical trial
- Medical or surgical procedure which might interfere with monitoring
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: "Usual care"
Patients will attend an appointment with the therapeutic education nurse before discharge, after which they will have no further contact with the education team.
The Research team members will telephone the patient three times during the year (after 2, 6 and 12 months) to collect data on HF treatments, blood tests results, health-related events and hospitalizations.
|
|
Experimental: Interventional
Before discharge, patients will attend an appointment with a nurse trained in therapeutic education, in which the nurse will evaluate the overall knowledge and the skills of the patient about HF. The nurse will then define specific educational objectives with the patient, based on the patient's medical history, state of disease, comorbidities, alarm signs, fears and knowledge. Each patient will receive six telephone calls and two home-visits during the 1 year of follow-up. Each contact between the nurse and the patient will be dedicated to HF education. The patient will also receive regular short text messages containing health advice and appointment reminders. To help the patient regain his/her autonomy, intervals between education sessions will be progressively longer. |
Interventional arm
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of rehospitalizations for acute heart failure (HF) in both groups of patients
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patients knowledge about the illness
Time Frame: 1 year
|
Nurses will evaluate during each telephone call and home visit patients knowledge and skills about the following items : illness, treatments, diet, physical activity, medical follow-up.
This data will be recorded in a specific table and classified into "acquired / partially acquired / not acquired" items.
|
1 year
|
Global quality of life
Time Frame: 1 year
|
Assessed by validated questionnaire SF-12
|
1 year
|
Quality of life linked to Heart Failure
Time Frame: 1 year
|
Assessed by validated questionnaire KCCQ-15
|
1 year
|
Length of stay for HF and all-cause hospitalizations
Time Frame: 1 year of follow-up
|
1 year of follow-up
|
|
Hospitalization rate for cardiovascular diseases except HF
Time Frame: 1 year of follow-up
|
1 year of follow-up
|
|
Cardiovascular and all-cause mortality rate
Time Frame: 1 year of follow-up
|
1 year of follow-up
|
|
B-type natriuretic peptide (BNP) or NT pro-BNP levels
Time Frame: During 1 year of follow-up
|
During 1 year of follow-up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cost effectiveness of the intervention
Time Frame: During 1 year of follow-up
|
Comparison between both groups of patients of the HF-hospitalizations average cost, related to the operating cost of the EduStra-HF method.
|
During 1 year of follow-up
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Ariel Cohen, MD PhD, Hopital Saint-Antoine
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EduStra-HF
- RCB ID: 2016-A00899-42 (Other Grant/Funding Number: National Drug and Health Products Safety Agency (ANSM))
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
University Hospital, MontpellierCompletedHeart Failure | Diastolic Heart Failure | Systolic Heart Failure Stage CFrance
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Giresun UniversityIstanbul University - Cerrahpasa (IUC)RecruitingHeart Failure | Diastolic Heart Failure | Systolic Heart FailureTurkey
-
Lancaster General HospitalLouise von Hess Medical Research InstituteEnrolling by invitationDiastolic Heart FailureUnited States
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
-
US Department of Veterans AffairsCompleted
Clinical Trials on Therapeutic education
-
Roy La Touche ArbizuUniversidad Autonoma de Madrid; Centro Universitario La Salle; Servicio Madrileño...UnknownLow Back Pain | Chronic Nonspecific Low Back PainSpain
-
Nantes University HospitalTerminated
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Assistance Publique - Hôpitaux de ParisCentre Leon Berard; Ministry of Health, France; Université Montpellier; Telecom... and other collaboratorsUnknownKidney Transplantation | End-stage Renal Disease | Dialysis
-
Beauvais HospitalNot yet recruitingNutrition Aspect of Cancer
-
University Hospital, Strasbourg, FranceNot yet recruitingAuto-immune Myasthenia
-
University Hospital, Clermont-FerrandFrench Society of RheumatologyCompletedRheumatoid Arthritis | SpondyloarthritisFrance
-
Hôpital Léon BérardWithdrawn
-
Association pour le Développement et l'Organisation...WithdrawnAlveolar HypoventilationFrance
-
Institut Pasteur de LilleAssociation Francaise pour la Recherche Thermale; Société des Etablissements... and other collaboratorsUnknown